Calcium Gluconate

CHEMBL2106119 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
430.4 g/mol
LogP
Phase
4

An injectable and oral form of calcium used to treat hypocalcemia, magnesium toxicity, and certain electrolyte emergencies. In obstetrics, intravenous calcium gluconate is the antidote for magnesium sulfate toxicity in treating severe preeclampsia. Oral forms are used to supplement calcium for bone health and vitamin D deficiency-related conditions.

分子量

430.3700 g/mol

TPSA

283.00 Ų

治療領域

作用機序

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Ca+2]

InChI

InChI=1S/2C6H12O7.Ca/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/m11./s1

Molecular Formula

C12H22CaO14

HBD / HBA

10 / 14

回転可能結合数

8

重原子数

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

An injectable and oral form of calcium used to treat hypocalcemia, magnesium toxicity, and certain electrolyte emergencies. In obstetrics, intravenous calcium gluconate is the antidote for magnesium sulfate toxicity in treating severe preeclampsia. Oral forms are used to supplement calcium for bone health and vitamin D deficiency-related conditions.

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Yes, Calcium Gluconate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2106119. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9290. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.